Register for free to
view the full innovation profile.
Peptoids and Methods for Attenuating Inflammatory Response
About
RAGE expression is low in most tissues in the young/healthy and increases in RAGE expression are associated with aging or conditions of chronic inflammation. Targeting RAGE could function as a preventative measure as well as a treatment option for a wide array of conditions (as previously mentioned). This is a method related to the reversing and/or inhibiting of RAGE expression in a cell. The future use of this technology is that of a method to reverse existing RAGE expression, as well as prevent RAGE expression with pre-treatment. It can potentially become a therapeutic for more diseases/conditions, in the future. For interested parties seeking further information, feel free to contact: Mark Allen Lanoue Technology Manager / Tech Ventures University of Arkansas (479) 575-7243 [email protected]
Key Benefits
The global peptide therapeutics market is expected to reach USD 48.04 billion by 2025, according to a new report by Grand View Research, Inc. Increasing demand for efficient & rapid-acting therapeutics for treatment of cancer and other lifestyle-associated disorders, which result in lesser adverse effects, are anticipated to propel market growth.
Applications
Targeting RAGE could function as a preventative measure as well as a treatment option for a wide array of conditions, as previously mentioned. Many diseases/conditions associated with aging and/or chronic inflammation, from specific diseases like Multiple Sclerosis and Alzheimer, disease, to conditions such as depression and obesity.